The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Attributable mortality burden of metabolic syndrome: comparison with its individual components.
Chi-Pang Wen; Hui-Ting Chan; Min-Kuang Tsai; Ting-Yuan D Cheng; Wen-Shen I Chung; Yen-Chen Chang; Hui-Ling Hsu; Shan-Pou Tsai; Chwen-Keng Tsao; Jackson Pui Man Wai; et al. (Profiled Author: Shan Tsai)
China Medical University Hospital, Taichung, Taiwan.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2011;18(4):561-73.
AIM: To estimate the national prevalence, mortality risk and population mortality burden of metabolic syndrome, and compare the values with those of its individual components. METHODS AND RESULTS: A total of 486,341 apparently healthy adults who went through a screening programme in Taiwan were recruited from 1994 onwards. As of 2007, 15,268 deaths had occurred at least one year after the examination. Six definitions of metabolic syndrome were used. Components of metabolic syndrome include obesity, hypertension, hyperglycaemia, dyslipidaemia and albuminuria. Hazard ratios (HRs) were calculated using the Cox proportional hazard model. The population mortality burden considered both national prevalence and HRs. The national prevalence of metabolic syndrome defined by the Adult Treatment Panel (ATP) III was 16.3%, the HR for all causes was 1.36 (95%, CI 1.31-1.41) and the HR for cardiovascular disease (CVD) was 1.63 (95%, CI 1.51-1.77). The population mortality burden of metabolic syndrome was 5.5% for all causes, in contrast to 9.0% for hypertension, 8.9% for albuminuria, 6.6% for diabetes, 3.5% for dyslipidaemia and 1.5% for obesity. For CVD it was 9.4%, lower than 10.7% for albuminuria and 25.0% for hypertension. CONCLUSION: The mortality burden of metabolic syndrome was relatively small at national level. Three of the five components of metabolic syndrome alone, namely hypertension, diabetes and albuminuria, contributed more than metabolic syndrome to all-cause mortality. Successful management of any of these three components would have achieved a greater impact on mortality than management of metabolic syndrome.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Takahisa Kondo; Shigeki Osugi; Keiko Shimokata; Haruo Honjo; Yasuhiro Morita; Kentaro Yamashita; Kengo Maeda; Takashi Muramatsu; Satoshi Shintani; Kunihiro Matsushita; et al.European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2011;18(4):574-80.
T-C Su; L-C Hwang; S-L You; C-J ChenJournal of human hypertension 2009;23(3):160-7.
Sadeka Shahani; Milena Braga-Basaria; Shehzad BasariaThe Journal of clinical endocrinology and metabolism 2008;93(6):2042-9.
Appears in this Publication
Author of this Publication